All Future of Bio/Pharma Analysis 2026 articles

News

Day one in focus: rethinking QA/QC at The Future of Bio/Pharmaceutical Analysis 2026

2026-05-21T08:24:00Z

The Future of Bio/Pharmaceutical Analysis Virtual Summit returns 23–25 June 2026 with an opening day dedicated entirely to quality assurance and control. Three expert-led panel sessions will address environmental monitoring modernisation, endotoxin testing transformation and contamination control optimisation—examining how QA/QC disciplines are adapting to advanced therapies, sustainability demands and evolving regulatory expectations including Annex 1 implementation.